Raise closed, search for fresh raises on Seedstage

Safety Harbor, FL

Transforming cardiac care with AI-powered implantable devices for improved patient outcomes.

• Mission: Transforming cardiac care through the development of AI-powered implantable devices that provide real-time monitoring for early detection and improved patient outcomes.  
• Innovation: A minimally invasive cardiac monitoring device that can be implanted in just two minutes, offering long-term data tracking for heart conditions such as arrhythmias and heart failure.  
• Technology Integration: Leverages advanced AI and multi-sensor data to track heart rhythms, sounds, pressures, and activity levels, enhancing the accuracy and reliability of monitoring.  
• Expertise: Backed by a team with over 200 years of combined experience in cardiology and medtech, with a proven history of successful exits and IPOs.  
• Strategic Partnerships: Collaborates with major institutions like Johnson & Johnson JLABS and Stanford’s StartX, positioning the company at the forefront of innovation in the cardiac device market.  
• Health Impact: Aims to reduce hospital visits, improve patient quality of life, and address the global healthcare burden of heart disease through personalized, continuous monitoring.  

Future Cardia is at the forefront of transforming cardiac care through the development of AI-powered implantable devices that enhance patient outcomes. The company aims to address the significant challenges posed by heart disease, a condition that affects millions globally and incurs substantial healthcare costs.

By creating a minimally invasive cardiac monitoring device that can be implanted in just two minutes, Future Cardia leverages advanced technology to provide near real-time data for early detection and intervention, ultimately reducing hospital visits and improving the quality of life for patients. The team behind Future Cardia boasts over 200 years of combined expertise in cardiology and medtech, with a strong track record of successful exits and IPOs.

Backed by notable investors and partnerships with institutions like Johnson & Johnson JLABS and Stanford’s StartX, Future Cardia is positioned to lead innovation in the $110 billion cardiac device market. The company’s vision includes achieving FDA approval and establishing itself as a key player in personalized healthcare, thereby revolutionizing how heart conditions are monitored and managed, and setting a new standard for cardiac care worldwide.

Company Info

Future Cardia specializes in innovative cardiac monitoring solutions through under-the-skin implantation devices.

Future Cardia is a company focused on advancing cardiac monitoring solutions, specifically targeting the challenges posed by cardiac arrhythmias and heart failure, which affect millions globally. Their innovative approach involves a simple, two-minute office procedure for under-the-skin implantation of a monitoring device, designed to provide long-term cardiac health monitoring. This device is classified as a Class II, 510K device, ensuring a streamlined regulatory process and existing insurance coverage. Future Cardia employs a multi-sensor data-driven approach, utilizing various technologies to monitor heart rhythms, sounds, pressures, and activity levels. The company boasts a team with over 200 years of combined expertise in cardiac device development and has garnered support from prominent advisors in the field. With a significant valuation and funding raised, Future Cardia aims to address the substantial healthcare problem associated with cardiac conditions, seeking to improve patient compliance and data accuracy compared to traditional wearable devices.